Form 4: Claritev Grants SVP Accounting Officer 2,825 RSUs
Insider Transaction Report
Claritev Corp granted its SVP, Chief Accounting Officer, Brock Albinson, 2,825 restricted stock units, vesting annually over four years.
Summary
- Brock Albinson, SVP, Chief Accounting Officer of Claritev Corp (CTEV), was granted 2,825 shares of Class A common stock.
- The transaction occurred on September 30, 2025, with a reported price of $0 per share, indicating a restricted stock unit (RSU) grant.
- These restricted stock units will vest at a rate of 25% per year on September 30, 2026, 2027, 2028, and 2029.
- Following this transaction, Mr. Albinson beneficially owns 2,825 shares directly.
Sentiment
Score: 6
Explanation: Slightly positive as it indicates executive retention and alignment with shareholder interests, which are generally viewed favorably. The impact is minor given the size of the grant.
Positives
- Aligns management's interests with long-term shareholder value through equity ownership.
- Serves as a retention mechanism for a key executive, the SVP, Chief Accounting Officer.
Negatives
- Potential for minor future share dilution upon vesting and conversion of the restricted stock units.
Future Outlook
The grant of restricted stock units is designed to incentivize long-term performance and retention, with vesting scheduled annually through September 30, 2029.
Industry Context
Granting restricted stock units to senior executives is a common practice in the U.S. corporate landscape, used to align executive incentives with shareholder interests and promote long-term retention.
Comparison to Industry Standards
- The use of Restricted Stock Units (RSUs) as a compensation component for senior executives like an SVP, Chief Accounting Officer, is a standard practice across various industries, including technology and finance, for companies of similar market capitalization to Claritev Corp.
- A four-year annual vesting schedule is typical for such equity awards, comparable to plans at companies like Microsoft, Apple, or Google for similar-level executives, though the specific number of units would vary significantly based on company size and executive role.
- The grant of 2,825 shares to an SVP/CAO is a modest but standard award for a company of potentially smaller to mid-market capitalization, aiming to provide meaningful equity participation without excessive dilution.
Stakeholder Impact
- Shareholders: Potential for minor future dilution upon vesting, but also benefits from increased executive alignment and retention.
- Employees: May signal stability in executive leadership and a commitment to long-term incentive programs.
Next Steps
- Vesting of 25% of the granted restricted stock units on September 30, 2026.
- Subsequent annual vesting of 25% of the RSUs on September 30, 2027, 2028, and 2029.
Key Dates
| Date | Description |
|---|---|
| 09/30/2025 | Date of RSU grant to Brock Albinson. |
| 10/01/2025 | Date Form 4 was signed and filed. |
| 09/30/2026 | First tranche (25%) of RSUs vest. |
| 09/30/2027 | Second tranche (25%) of RSUs vest. |
| 09/30/2028 | Third tranche (25%) of RSUs vest. |
| 09/30/2029 | Final tranche (25%) of RSUs vest. |
Recommendation
holdThis Form 4 filing reports a routine executive compensation grant and does not contain information that would fundamentally alter the investment thesis for Claritev Corp. It is a standard practice for executive retention and alignment, not a catalyst for a 'buy' or 'sell' recommendation on its own.
Keywords
Claritev Corp, CTEV, Brock Albinson, Restricted Stock Units, RSU Grant, Executive Compensation, Insider Transaction, Equity Award, SVP Chief Accounting Officer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.